Titre:
  • A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.
Auteur:Mestre, Leyre; Docagne, Fabian; Correa, Fernando; Loría, Frida; Hernangomez Herrero, Miriam; Borrell, J.; Guaza, Carmen
Informations sur la publication:Molecular and cellular neurosciences, 40, 2, page (258-266)
Statut de publication:Publié, 2009-02
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Animals
Behavior, Animal -- physiology
Benzoxazines -- pharmacology
Calcium Channel Blockers -- pharmacology
Cannabinoids -- agonists -- pharmacology -- therapeutic use
Cardiovirus Infections -- physiopathology
Disease Models, Animal
Disease Progression
Endothelium -- cytology -- drug effects -- metabolism
Female
Humans
Intercellular Adhesion Molecule-1 -- genetics -- metabolism
Mice
Morpholines -- pharmacology
Motor Activity -- physiology
Multiple Sclerosis -- drug therapy -- pathology -- physiopathology
Naphthalenes -- pharmacology
PPAR gamma -- metabolism
Receptor, Cannabinoid, CB1 -- metabolism
Receptor, Cannabinoid, CB2 -- metabolism
Theilovirus -- metabolism
Vascular Cell Adhesion Molecule-1 -- genetics -- metabolism
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:1044-7431
info:doi/10.1016/j.mcn.2008.10.015
info:pii/S1044-7431(08)00290-X
info:pmid/19059482